COLLEYVILLE, Texas, Aug. 28, 2019 /PRNewswire/ — Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first FDA (510k) cleared magnesium-based bone void filler in the orthopedic marketplace, designed to assist with bone repair and regeneration. Onkos intends to distribute and market the products under the GenVie™ brand name. OsteoCrete® is an injectable, …